Global Next Generation Cancer Diagnostics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Next Generation Cancer Diagnostics Market Size 2017-2028

2.1.2 Next Generation Cancer Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Next Generation Cancer Diagnostics Segment by Type

2.2.1 Next Generation Sequencing

2.2.2 qPCR & Multiplexing

2.2.3 DNA Microarrays

2.2.4 Others

2.3 Next Generation Cancer Diagnostics Market Size by Type

2.3.1 Next Generation Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)

2.4 Next Generation Cancer Diagnostics Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Next Generation Cancer Diagnostics Market Size by Application

2.5.1 Next Generation Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)

3 Next Generation Cancer Diagnostics Market Size by Player

3.1 Next Generation Cancer Diagnostics Market Size Market Share by Players

3.1.1 Global Next Generation Cancer Diagnostics Revenue by Players (2020-2022)

3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2020-2022)

3.2 Global Next Generation Cancer Diagnostics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Next Generation Cancer Diagnostics by Regions

4.1 Next Generation Cancer Diagnostics Market Size by Regions (2017-2022)

4.2 Americas Next Generation Cancer Diagnostics Market Size Growth (2017-2022)

4.3 APAC Next Generation Cancer Diagnostics Market Size Growth (2017-2022)

4.4 Europe Next Generation Cancer Diagnostics Market Size Growth (2017-2022)

4.5 Middle East & Africa Next Generation Cancer Diagnostics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Next Generation Cancer Diagnostics Market Size by Country (2017-2022)

5.2 Americas Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

5.3 Americas Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Next Generation Cancer Diagnostics Market Size by Region (2017-2022)

6.2 APAC Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

6.3 APAC Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Next Generation Cancer Diagnostics by Country (2017-2022)

7.2 Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

7.3 Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Next Generation Cancer Diagnostics by Region (2017-2022)

8.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

8.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Next Generation Cancer Diagnostics Market Forecast

10.1 Global Next Generation Cancer Diagnostics Forecast by Regions (2023-2028)

10.1.1 Global Next Generation Cancer Diagnostics Forecast by Regions (2023-2028)

10.1.2 Americas Next Generation Cancer Diagnostics Forecast

10.1.3 APAC Next Generation Cancer Diagnostics Forecast

10.1.4 Europe Next Generation Cancer Diagnostics Forecast

10.1.5 Middle East & Africa Next Generation Cancer Diagnostics Forecast

10.2 Americas Next Generation Cancer Diagnostics Forecast by Country (2023-2028)

10.2.1 United States Next Generation Cancer Diagnostics Market Forecast

10.2.2 Canada Next Generation Cancer Diagnostics Market Forecast

10.2.3 Mexico Next Generation Cancer Diagnostics Market Forecast

10.2.4 Brazil Next Generation Cancer Diagnostics Market Forecast

10.3 APAC Next Generation Cancer Diagnostics Forecast by Region (2023-2028)

10.3.1 China Next Generation Cancer Diagnostics Market Forecast

10.3.2 Japan Next Generation Cancer Diagnostics Market Forecast

10.3.3 Korea Next Generation Cancer Diagnostics Market Forecast

10.3.4 Southeast Asia Next Generation Cancer Diagnostics Market Forecast

10.3.5 India Next Generation Cancer Diagnostics Market Forecast

10.3.6 Australia Next Generation Cancer Diagnostics Market Forecast

10.4 Europe Next Generation Cancer Diagnostics Forecast by Country (2023-2028)

10.4.1 Germany Next Generation Cancer Diagnostics Market Forecast

10.4.2 France Next Generation Cancer Diagnostics Market Forecast

10.4.3 UK Next Generation Cancer Diagnostics Market Forecast

10.4.4 Italy Next Generation Cancer Diagnostics Market Forecast

10.4.5 Russia Next Generation Cancer Diagnostics Market Forecast

10.5 Middle East & Africa Next Generation Cancer Diagnostics Forecast by Region (2023-2028)

10.5.1 Egypt Next Generation Cancer Diagnostics Market Forecast

10.5.2 South Africa Next Generation Cancer Diagnostics Market Forecast

10.5.3 Israel Next Generation Cancer Diagnostics Market Forecast

10.5.4 Turkey Next Generation Cancer Diagnostics Market Forecast

10.5.5 GCC Countries Next Generation Cancer Diagnostics Market Forecast

10.6 Global Next Generation Cancer Diagnostics Forecast by Type (2023-2028)

10.7 Global Next Generation Cancer Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Cepheid

11.1.1 Cepheid Company Information

11.1.2 Cepheid Next Generation Cancer Diagnostics Product Offered

11.1.3 Cepheid Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Cepheid Main Business Overview

11.1.5 Cepheid Latest Developments

11.2 Koninklijke Philips N.V

11.2.1 Koninklijke Philips N.V Company Information

11.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Offered

11.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Koninklijke Philips N.V Main Business Overview

11.2.5 Koninklijke Philips N.V Latest Developments

11.3 F. Hoffmann-La Roche Ltd

11.3.1 F. Hoffmann-La Roche Ltd Company Information

11.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Offered

11.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.3.5 F. Hoffmann-La Roche Ltd Latest Developments

11.4 Qiagen

11.4.1 Qiagen Company Information

11.4.2 Qiagen Next Generation Cancer Diagnostics Product Offered

11.4.3 Qiagen Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Qiagen Main Business Overview

11.4.5 Qiagen Latest Developments

11.5 Novartis AG

11.5.1 Novartis AG Company Information

11.5.2 Novartis AG Next Generation Cancer Diagnostics Product Offered

11.5.3 Novartis AG Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Novartis AG Main Business Overview

11.5.5 Novartis AG Latest Developments

11.6 Abbott

11.6.1 Abbott Company Information

11.6.2 Abbott Next Generation Cancer Diagnostics Product Offered

11.6.3 Abbott Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Abbott Main Business Overview

11.6.5 Abbott Latest Developments

11.7 Thermo Fisher Scientific

11.7.1 Thermo Fisher Scientific Company Information

11.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Offered

11.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Thermo Fisher Scientific Main Business Overview

11.7.5 Thermo Fisher Scientific Latest Developments

11.8 Opko Health

11.8.1 Opko Health Company Information

11.8.2 Opko Health Next Generation Cancer Diagnostics Product Offered

11.8.3 Opko Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Opko Health Main Business Overview

11.8.5 Opko Health Latest Developments

11.9 Myriad Genetics

11.9.1 Myriad Genetics Company Information

11.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Offered

11.9.3 Myriad Genetics Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Myriad Genetics Main Business Overview

11.9.5 Myriad Genetics Latest Developments

11.10 Agilent Technologies

11.10.1 Agilent Technologies Company Information

11.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Offered

11.10.3 Agilent Technologies Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Agilent Technologies Main Business Overview

11.10.5 Agilent Technologies Latest Developments

11.11 GE Healthcare

11.11.1 GE Healthcare Company Information

11.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Offered

11.11.3 GE Healthcare Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 GE Healthcare Main Business Overview

11.11.5 GE Healthcare Latest Developments

11.12 PerkinElmer

11.12.1 PerkinElmer Company Information

11.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Offered

11.12.3 PerkinElmer Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 PerkinElmer Main Business Overview

11.12.5 PerkinElmer Latest Developments

11.13 Genomic Health

11.13.1 Genomic Health Company Information

11.13.2 Genomic Health Next Generation Cancer Diagnostics Product Offered

11.13.3 Genomic Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Genomic Health Main Business Overview

11.13.5 Genomic Health Latest Developments

11.14 Illumina

11.14.1 Illumina Company Information

11.14.2 Illumina Next Generation Cancer Diagnostics Product Offered

11.14.3 Illumina Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Illumina Main Business Overview

11.14.5 Illumina Latest Developments

11.15 Hologic

11.15.1 Hologic Company Information

11.15.2 Hologic Next Generation Cancer Diagnostics Product Offered

11.15.3 Hologic Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Hologic Main Business Overview

11.15.5 Hologic Latest Developments

11.16 Almac Group

11.16.1 Almac Group Company Information

11.16.2 Almac Group Next Generation Cancer Diagnostics Product Offered

11.16.3 Almac Group Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Almac Group Main Business Overview

11.16.5 Almac Group Latest Developments

11.17 Janssen Global Services

11.17.1 Janssen Global Services Company Information

11.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Offered

11.17.3 Janssen Global Services Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Janssen Global Services Main Business Overview

11.17.5 Janssen Global Services Latest Developments

11.18 Sysmex Corporation

11.18.1 Sysmex Corporation Company Information

11.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Offered

11.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Sysmex Corporation Main Business Overview

11.18.5 Sysmex Corporation Latest Developments

12 Research Findings and Conclusion

Table 1. Next Generation Cancer Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Next Generation Sequencing

Table 3. Major Players of qPCR & Multiplexing

Table 4. Major Players of DNA Microarrays

Table 5. Major Players of Others

Table 6. Next Generation Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)

Table 9. Next Generation Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)

Table 12. Global Next Generation Cancer Diagnostics Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Next Generation Cancer Diagnostics Revenue Market Share by Player (2020-2022)

Table 14. Next Generation Cancer Diagnostics Key Players Head office and Products Offered

Table 15. Next Generation Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Next Generation Cancer Diagnostics Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Next Generation Cancer Diagnostics Market Size Market Share by Regions (2017-2022)

Table 20. Americas Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Next Generation Cancer Diagnostics Market Size Market Share by Country (2017-2022)

Table 22. Americas Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)

Table 24. Americas Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)

Table 26. APAC Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Next Generation Cancer Diagnostics Market Size Market Share by Region (2017-2022)

Table 28. APAC Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)

Table 30. APAC Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)

Table 32. Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Next Generation Cancer Diagnostics Market Size Market Share by Country (2017-2022)

Table 34. Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)

Table 36. Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Next Generation Cancer Diagnostics

Table 45. Key Market Challenges & Risks of Next Generation Cancer Diagnostics

Table 46. Key Industry Trends of Next Generation Cancer Diagnostics

Table 47. Global Next Generation Cancer Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Next Generation Cancer Diagnostics Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Next Generation Cancer Diagnostics Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Next Generation Cancer Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Next Generation Cancer Diagnostics Market Size Market Share Forecast by Application (2023-2028)

Table 53. Cepheid Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 54. Cepheid Next Generation Cancer Diagnostics Product Offered

Table 55. Cepheid Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Cepheid Main Business

Table 57. Cepheid Latest Developments

Table 58. Koninklijke Philips N.V Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 59. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Offered

Table 60. Koninklijke Philips N.V Main Business

Table 61. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Koninklijke Philips N.V Latest Developments

Table 63. F. Hoffmann-La Roche Ltd Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 64. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Offered

Table 65. F. Hoffmann-La Roche Ltd Main Business

Table 66. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. F. Hoffmann-La Roche Ltd Latest Developments

Table 68. Qiagen Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 69. Qiagen Next Generation Cancer Diagnostics Product Offered

Table 70. Qiagen Main Business

Table 71. Qiagen Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Qiagen Latest Developments

Table 73. Novartis AG Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 74. Novartis AG Next Generation Cancer Diagnostics Product Offered

Table 75. Novartis AG Main Business

Table 76. Novartis AG Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Novartis AG Latest Developments

Table 78. Abbott Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 79. Abbott Next Generation Cancer Diagnostics Product Offered

Table 80. Abbott Main Business

Table 81. Abbott Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Abbott Latest Developments

Table 83. Thermo Fisher Scientific Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 84. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Offered

Table 85. Thermo Fisher Scientific Main Business

Table 86. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Thermo Fisher Scientific Latest Developments

Table 88. Opko Health Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 89. Opko Health Next Generation Cancer Diagnostics Product Offered

Table 90. Opko Health Main Business

Table 91. Opko Health Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Opko Health Latest Developments

Table 93. Myriad Genetics Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 94. Myriad Genetics Next Generation Cancer Diagnostics Product Offered

Table 95. Myriad Genetics Main Business

Table 96. Myriad Genetics Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Myriad Genetics Latest Developments

Table 98. Agilent Technologies Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 99. Agilent Technologies Next Generation Cancer Diagnostics Product Offered

Table 100. Agilent Technologies Main Business

Table 101. Agilent Technologies Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Agilent Technologies Latest Developments

Table 103. GE Healthcare Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 104. GE Healthcare Next Generation Cancer Diagnostics Product Offered

Table 105. GE Healthcare Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. GE Healthcare Main Business

Table 107. GE Healthcare Latest Developments

Table 108. PerkinElmer Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 109. PerkinElmer Next Generation Cancer Diagnostics Product Offered

Table 110. PerkinElmer Main Business

Table 111. PerkinElmer Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. PerkinElmer Latest Developments

Table 113. Genomic Health Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 114. Genomic Health Next Generation Cancer Diagnostics Product Offered

Table 115. Genomic Health Main Business

Table 116. Genomic Health Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Genomic Health Latest Developments

Table 118. Illumina Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 119. Illumina Next Generation Cancer Diagnostics Product Offered

Table 120. Illumina Main Business

Table 121. Illumina Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Illumina Latest Developments

Table 123. Hologic Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 124. Hologic Next Generation Cancer Diagnostics Product Offered

Table 125. Hologic Main Business

Table 126. Hologic Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Hologic Latest Developments

Table 128. Almac Group Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 129. Almac Group Next Generation Cancer Diagnostics Product Offered

Table 130. Almac Group Main Business

Table 131. Almac Group Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. Almac Group Latest Developments

Table 133. Janssen Global Services Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 134. Janssen Global Services Next Generation Cancer Diagnostics Product Offered

Table 135. Janssen Global Services Main Business

Table 136. Janssen Global Services Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. Janssen Global Services Latest Developments

Table 138. Sysmex Corporation Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors

Table 139. Sysmex Corporation Next Generation Cancer Diagnostics Product Offered

Table 140. Sysmex Corporation Main Business

Table 141. Sysmex Corporation Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 142. Sysmex Corporation Latest Developments

List of Figures

Figure 1. Next Generation Cancer Diagnostics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Next Generation Cancer Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Next Generation Cancer Diagnostics Market Size Market Share by Type in 2021

Figure 7. Next Generation Cancer Diagnostics in Hospitals

Figure 8. Global Next Generation Cancer Diagnostics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Next Generation Cancer Diagnostics in Clinics

Figure 10. Global Next Generation Cancer Diagnostics Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Next Generation Cancer Diagnostics in Others

Figure 12. Global Next Generation Cancer Diagnostics Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021

Figure 14. Global Next Generation Cancer Diagnostics Revenue Market Share by Player in 2021

Figure 15. Global Next Generation Cancer Diagnostics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Next Generation Cancer Diagnostics Value Market Share by Country in 2021

Figure 21. Americas Next Generation Cancer Diagnostics Consumption Market Share by Type in 2021

Figure 22. Americas Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021

Figure 23. United States Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Next Generation Cancer Diagnostics Market Size Market Share by Region in 2021

Figure 28. APAC Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021

Figure 29. China Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Next Generation Cancer Diagnostics Market Size Market Share by Country in 2021

Figure 36. Europe Next Generation Cancer Diagnostics Market Size Market Share by Type in 2021

Figure 37. Europe Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021

Figure 38. Germany Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021

Figure 46. Egypt Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 55. United States Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 59. China Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 63. India Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 66. France Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 67. UK Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)